Delivery Order SPE2DB20D2104-SPE2DB25FMJFM
Award Date
2/18/25
Potential Completion Date
2/19/25
Potential Value
$27K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award SPE2DB25D3001|SPE2DB25FQTXA was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of XIFAXAN 550 mg tablets. The contract has a ceiling value of $4,141.30 and a completion date of January 23, 2025. It is a firm-fixed-price delivery order contract, without any set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
This federal contract award, identified as SPE2DB22D3301|SPE2DB24FZ1ED, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $23,686.65 and a completion date of July 23, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award, with the ID SPE2DB22D1106|SPE2DB25FDSC5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a total ceiling value of $68,618.48. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 30, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FNS81, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $25,204.50, is for the delivery of 60 tablets of the pharmaceutical product XIFAXAN 550 MG. The contract has an ultimate completion date of December 6, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award, with ID SPE2DB20D2001|SPE2DB24FM72X, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,691.54, is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of XIFAXAN 550 MG TABLET 60S. The contract has a ceiling value of $17,572.67 and runs through May 30, 2024. It is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with the identification number SPE2DB20D1050|SPE2DB25FH33R, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $19,162.99 delivery order contract is for the pharmaceutical product XIFAXAN 550 MG TABLET 60S. The contract has a firm fixed price pricing type and an ultimate completion date of October 29, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds an...
This federal contract award, valued at $11,806.49, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of January 9, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, with an ID of SPE2DB20D2104|SPE2DB25FMHUL, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $8,747.45 and a period of performance through February 11, 2025. It is not designated as a set-aside contract....
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,703.10 firm fixed-price delivery order is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 26, 2025 and was awarded on February 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...